Hereditary Breast and Ovarian Cancer
19
5
7
8
Key Insights
Highlights
Success Rate
80% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
10.5%
2 terminated out of 19 trials
80.0%
-6.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 8 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 8 completed trials
Clinical Trials (19)
Familial Investigations of Childhood Cancer Predisposition
Scalable Communication Modalities for Returning Genetic Research Results
Radical Fimbriectomy for Young BRCA Mutation Carriers
Cancer Genetics Hereditary Cancer Panel Testing
Sequential EHR Based Interventions to Increase Genetic Testing for Breast and Ovarian Cancer Predisposition
Triple Negative Breast Cancer and Germline Hereditary Breast and Ovarian Cancer Mutation Carrier Registry
CONTIGO - A Narrative Intervention to Enhance Genetic Counseling and Testing
Cascade Genetic Testing for Hereditary Breast/Ovarian Cancer and Lynch Syndrome in Switzerland
Investigation of Tumour Spectrum of Germline Mutations in Breast and Ovarian Cancer Genes.
Implementation of the Families Accelerating Cascade Testing Toolkit (FACTT) for Hereditary Breast and Ovarian Cancer and Lynch Syndrome
Feasibility of Lifestyle Intervention in BRCA1/2 Mutation Carriers
Efficacy of Lifestyle Intervention in BRCA1/2 Mutation Carriers
Multifactorial Risk Assessment for Breast & Ovarian Cancer Risk Detection
Study of Quality of Life Post Salpingo-oophorectomy in BRCA1/2 & PALB2 Mutation Carriers (BRCA-HRT)
Testing an Intelligent Tutoring System to Enhance Genetic Risk Assessment
Enhancing At-risk Latina Women's Use of Genetic Counseling for Hereditary Breast and Ovarian Cancer
Evaluation of the Adhesion to the GENEPY Network
Genetic Risk: Whether, When, and How to Tell Adolescents
Identification and Referral of Women at Risk for Hereditary Breast/Ovarian Cancer